SCHEMBL3671086

SCHEMBL3671086

O=C(O)Oc1sccc1O

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.33
MEN1 O00255 3/20 0.33
MAPT P10636 3/20 0.33
ALDH1A1 P00352 2/20 0.33
MAPK1 P28482 1/20 0.33
LMNA P02545 3/20 0.32
GPR35 Q9HC97 2/20 0.32
HSD17B10 Q99714 2/20 0.32
USP2 O75604 1/20 0.32
GLA P06280 1/20 0.32
POLB P06746 1/20 0.32
NR4A1 P22736 1/20 0.32
RECQL P46063 1/20 0.32
ESR2 Q92731 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
AXL P30530 1/20 0.32
DAO P14920 1/20 0.31
HCAR2 Q8TDS4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27997449 0.85 LMNA (0.38) MAPTALDH1A1LMNAHSD17B10POLB
SCHEMBL3672729 0.82 KDM4E (0.37) KMT2AMEN1MAPTALDH1A1LMNA
SCHEMBL9351950 0.78 GSK3B (0.41) KMT2AMEN1MAPTPOLBNR4A1
SCHEMBL10587921 0.78 KMT2A (0.37) KMT2AMEN1MAPTALDH1A1LMNA
SCHEMBL10369277 0.77 KDM4E (0.33) KMT2AMEN1MAPTALDH1A1MAPK1
SCHEMBL4634541 0.77 KMT2A (0.36) KMT2AMEN1MAPTALDH1A1MAPK1
SCHEMBL17629372 0.77 MAPT (0.33) KMT2AMEN1MAPTALDH1A1MAPK1
SCHEMBL4636562 0.77 MAPT (0.40) KMT2AMEN1MAPTALDH1A1LMNA
SCHEMBL3418797 0.77 POLB (0.40) KMT2AMEN1MAPTALDH1A1LMNA
SCHEMBL10968934 0.75 KEAP1 (0.41) KMT2AMEN1MAPK1POLBRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1964844-B1 New thiophen glycoside derivatives, method for their manufacture, medicines containing these compounds and their application SANOFI AVENTIS DEUTSCHLAND (DE) 2010-09-01 EP disclosed
EP-1964845-B1 New thiophen glycoside derivatives, method for their manufacture, medicines containing these compounds and their application SANOFI AVENTIS DEUTSCHLAND (DE) 2010-08-11 EP disclosed
EP-1967523-B1 New thiophen glycoside derivatives, method for their manufacture, medicines containing these compounds and their application SANOFI AVENTIS DEUTSCHLAND (DE) 2010-08-11 EP disclosed
EP-1523488-B1 NOVEL THIOPHENYLGLYCOSIDE DERIVATIVES, METHODS FOR PRODUCTION THEREOF, MEDICAMENTS COMPRISING SAID COMPOUNDS AND USE THEREOF SANOFI AVENTIS DEUTSCHLAND (DE) 2008-11-12 EP disclosed
EP-1967523-A1 New thiophen glycoside derivatives, method for their manufacture, medicines containing these compounds and their application Sanofi-Aventis Deutschland GmbH (DE) 2008-09-10 EP disclosed
EP-1964845-A1 New thiophen glycoside derivatives, method for their manufacture, medicines containing these compounds and their application Sanofi-Aventis Deutschland GmbH (DE) 2008-09-03 EP disclosed
EP-1964844-A1 New thiophen glycoside derivatives, method for their manufacture, medicines containing these compounds and their application Sanofi-Aventis Deutschland GmbH (DE) 2008-09-03 EP disclosed
EP-1523488-A1 NOVEL THIOPHENYLGLYCOSIDE DERIVATIVES, METHODS FOR PRODUCTION THEREOF, MEDICAMENTS COMPRISING SAID COMPOUNDS AND USE THEREOF Aventis Pharma Deutschland GmbH (DE) 2005-04-20 EP disclosed
WO-2004007517-A1 NOVEL THIOPHENYLGLYCOSIDE DERIVATIVES, METHODS FOR PRODUCTION THEREOF, MEDICAMENTS COMPRISING SAID COMPOUNDS AND USE THEREOF AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2004-01-22 WO disclosed